Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octaplex dose comparison in anticoagulant-related cerebral hemorrhage
2007-000602-73Phase 4Completed
- Sponsor
- Octapharma
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of coagulation factor X human in intracerebral hemorrhage (ICH) and Anticoagulant-induced coagulopathy (2 arms), sponsored by Octapharma. Primary endpoint: INR correction shortly after infusion. Started Mar 2007; status: completed.
02
Drugs
coagulation factor X human
03
Conditions
intracerebral hemorrhage (ICH)Anticoagulant-induced coagulopathy
Beyond the preview
Go deeper on 2007-000602-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000602-73.